Forex ziņas
RBA Minutes On Tap For Tuesday
The Reserve Bank of Australia will on Tuesday release the minutes from its May 7 monetary policy meeting, highlighting a light day for Asia-Pacific economic activity.
RTTNews |
4h 26min ago
Dollar Stays Firm Against Major Counterparts
The U.S. dollar stayed largely positive on Monday with traders assessing the likely moves of the Federal Reserve with regard to interest rates.
RTTNews
|
5h 25min ago
SMI Hits New 52-week High, Ends On Strong Note Again
The Switzerland market ended on a firm note on Monday, extending its long winning streak, as the mood continued to remain positive thanks to strong quarterly earnings, and expectations of interest rate cuts.
RTTNews
|
8h 47min ago
European Stocks Close Broadly Higher After Cautious Session
European stocks closed a bit higher on Monday as expectations that the stimulus measures announced by China last week will help revive the property sector in the world's second largest economy, and optimism about interest rate cuts in the coming months helped underpin sentiment in European markets.
RTTNews
|
9h 18min ago
Jabil Confirms Q3 Outlook; Withdraws FY25 Outlook; Appoints Michael Dastoor CEO, Gregory Hebard CFO
Jabil Inc. (JBL) announced Monday it is confirming the previously provided third-quarter guidance for net revenue of $6.2 billion to $6.8 billion, earnings of $0.82 to $1.38 per share and core earnings of $1.65 to $2.05 per share.
RTTNews
|
11h 51min ago
U.S. Dollar Dropped Last Week On Softer Inflation
An expected softening in inflation readings in the U.S. triggered the U.S. dollar's decline against major currencies during the week ended May 17.
RTTNews
|
12h 36min ago
Kyndryl Partners NVIDIA To Offer AI-Powered Business Solutions
Kyndryl Holdings, Inc. (KD), a technology infrastructure services provider, announced Monday a collaboration with NVIDIA Corp. (NVDA) to accelerate the development, implementation and use of AI-powered insights and business outcomes.
RTTNews
|
13h 11min ago
more news
GM Defense, Mistral Ink Strategic Collaboration To Enhance Tactical Capability
GM Defense, a subsidiary of General Motors Co. (GM), and Mistral, Inc., announced Monday the integration of the innovative UVision and Mistral's Hero-120 loitering munition with GM Defense's light tactical utility vehicle.
RTTNews
|
13h 40min ago
CervoMed Appoints William Elder To Succeed William Tanner As CFO
Clinical stage company CervoMed Inc. (CRVO) announced Monday the appointment of William Elder as Chief Financial Officer, effective June 1, 2024. Elder will continue to serve as General Counsel and Corporate Secretary.
RTTNews
|
13h 56min ago
Thailand GDP Growth Exceeds Expectations
Thailand's economy grew more than expected in the first quarter, driven by household consumption and growth in tourist arrivals, official data revealed Monday. Gross domestic product grew at a slower pace of 1.5 percent on a yearly basis, which was slower than the 1.7 percent expansion in the preceding quarter, the National Economic and Social Development Council reported.
RTTNews
|
14h 0min ago
Exelixis Resolves Two CABOMETYX Patent Disputes With Cipla
Exelixis, Inc. (EXEL) announced Monday that it has entered into a Settlement and License Agreement with Cipla Ltd. and Cipla USA, Inc. to resolve two patent litigations brought by Exelixis in response to Cipla's Abbreviated New Drug Application (ANDA) seeking approval to market generic versions of CABOMETYX (cabozantinib) tablets prior to the expiration of the applicable patents.
RTTNews
|
14h 8min ago
CyberArk To Acquire Venafi From Thoma Bravo For About $1.54 Bln Cash And Stock
Identity security company CyberArk Software Ltd. (CYBR) announced Monday it has signed a definitive agreement to acquire machine identity management firm Venafi from Thoma Bravo in a cash and stock deal valued at about $1.54 billion. The consideration includes approximately $1 billion in cash and approximately $540 million in shares.
RTTNews
|
15h 5min ago
PTC Therapeutics Says European Commission Returns Translarna Opinion To CHMP For Re-evaluation
PTC Therapeutics, Inc. (PTCT) announced Monday that the European Commission (EC) has decided not to adopt the CHMP's negative opinion of January 24, 2024 on the annual renewal of the conditional marketing authorization of Translarna (ataluren) and has returned the opinion to the CHMP for re-evaluation.
RTTNews
|
15h 18min ago
Stay up to date!
Add News to your browser
